Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes

Journal of Endocrinological Investigation

Volumn 39, Issue 2, 2016, Pages 159-167

  Mantovani, A ^a   Rigolon, R ^a   Pichiri, I ^a   Pernigo, M ^a   Bergamini, C ^a   Zoppini, G ^a   Bonora, E ^a   Targher, G ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Arrhythmia; Atrial fibrillation; Cardiovascular disease; Serum uric acid; Type 2 diabetes

Indexed keywords

ALBUMIN; ALLOPURINOL; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGOXIN; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXIDASE; TRIACYLGLYCEROL; URATE OXIDASE; URIC ACID; ANTIGOUT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATRIAL FIBRILLATION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ELECTROCARDIOGRAM; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONAL EXPERIENCE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX ALLOCATION; SMOKING; URIC ACID BLOOD LEVEL; VALVULAR HEART DISEASE; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC CARDIOMYOPATHIES; ELECTRONIC HEALTH RECORD; GOUT; HOSPITALIZATION; ITALY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; UNIVERSITY HOSPITAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLOPURINOL; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ELECTRONIC HEALTH RECORDS; FEMALE; GOUT; GOUT SUPPRESSANTS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYPERURICEMIA; ITALY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK; URIC ACID;

EID: 84955290078     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0354-z     Document Type: Article

References (28)

1. Lip GY, Tse HF, Lane DA (2012) Atrial fibrillation. Lancet 379:648-661
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted Country, Minnesota, 1980-2000, and implications on the projections for future prevalence. Circulation 114:119-125
3. Rahman F, Kwan GF, Benjamin EJ (2014) Global epidemiology of atrial fibrillation. Nat Rev Cardiol 11:639-654
4. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7-13
5. Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811-1821
6. Zoppini G, Targher G, Bonora E (2011) The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects. A narrative review. J Endocrinol Invest 34:881-886
7. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA (2007) Serum uric acid and brain ischemia in normal elderly adults. Neurology 69:1418-1423
8. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546-1551
9. Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M, Bonora E (2009) Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 32:1716-1720
10. Jalal DI, Chonchol M, Chen W, Targher G (2013) Uric acid as a target of therapy in CKD. Am J Kidney Dis 61:134-146
11. Chao TF, Hung CL, Chen SJ, Wang KL, Chen TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen SA (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027-4032
12. Chuang SY, Wu CC, Hsu PF, Chia-Yu Chen R, Liu WL, Hsu YY, Pan WH (2014) Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. Nutr Metab Cardiovasc Dis 24:1020-1026
13. Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354:2473-2483
14. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC, AHA Task Force Members (2014) 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:2071-2104
15. Vanezis AP (2008) Bhopal R (2008) Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard. J Electrocardiol 41:404-412
16. Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM (2014) Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 11:1102-1108
17. Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, Byrne CD (2013) Targher G (2013) Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 112:499-504
18. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759-766
19. Papežíková I, Pekarová M, Kolářová H, Klinke A, Lau D, Baldus S, Lojek A, Kubala L (2013) Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res 47:82-88
20. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739-1742
21. Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 59:235-242
22. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26:269-275
23. Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553-3562
24. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886-2891
25. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006-3010
26. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular health study. Circulation 120:1768-1774
27. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, Tofler GH, Selhub J, Jacques PF, Wolf PA, Magnani JW, Ellinor PT, Wang TJ, Levy D, Vasan RS, Benjamin EJ (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121:200-207
28. Hu YF, Chen YJ, Lin YJ, Chen SA (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12:230-243